Biotech · Private company
SynerGene Therapeutics, Inc.
Track this companyFree. Adds SynerGene Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- GemcitabinePhase 2 · Metastatic Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- nab-paclitaxelPhase 2 · Metastatic Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- SGT-53Phase 2 · RECURRENT GLIOBLASTOMAClinicalTrials.gov · fetched Nov 12, 2026
- SGT-53Phase 2 · Metastatic Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 2 · RECURRENT GLIOBLASTOMAClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 1 · Childhood CNS TumorClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- IrinotecanPhase 1 · Childhood CNS TumorClinicalTrials.gov · fetched Nov 12, 2026
- RadiationPhase 1 · Childhood CNS TumorClinicalTrials.gov · fetched Nov 12, 2026
- SGT-53Phase 1 · Childhood CNS TumorClinicalTrials.gov · fetched Nov 12, 2026
- SGT-53Phase 1 · NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 1 · Childhood CNS TumorClinicalTrials.gov · fetched Nov 12, 2026
- TopotecanPhase 1 · NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- SGT-53 in Children With Recurrent or Progressive CNS MalignanciesEARLY_PHASE1 · WITHDRAWN · started Jun 1, 2022ClinicalTrials.gov NCT03554707 · fetched Nov 12, 2026
- Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 1, 2015ClinicalTrials.gov NCT02340117 · fetched Nov 12, 2026
- A Study of SGT-53 in Children With Refractory or Recurrent Solid TumorsPHASE1 · SUSPENDED · started Dec 1, 2014ClinicalTrials.gov NCT02354547 · fetched Nov 12, 2026
- Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent GlioblastomaPHASE2 · TERMINATED · started Dec 1, 2014ClinicalTrials.gov NCT02340156 · fetched Nov 12, 2026